Long acting insulin composition

作者: Kennett Sprogøe , Thomas Wegge , Silvia Kaden-Vagt , Harald Rau , Torben Lessmann

DOI:

关键词:

摘要: The present invention relates to a pharmaceutical composition comprising an insulin compound in concentration that is sufficient maintain therapeutically effective level of the blood plasma for at least 3 days characterized by having pharmacokinetic profile vivo with substantially no burst compound. further use preparing said as well kit parts composition.

参考文章(161)
Abraham J Domb, Ludmila Turovsky, Raphael Nudelman, None, Chemical interactions between drugs containing reactive amines with hydrolyzable insoluble biopolymers in aqueous solutions. Pharmaceutical Research. ,vol. 11, pp. 865- 868 ,(1994) , 10.1023/A:1018985909777
Magali Zundel, Florencio Doerwald Zaragoza, Bernd Pesckhe, Peptide compounds with transient biodegradable pegylation ,(2008)
Dirk Vetter, Harald Rau, Tobias Voigt, Ulrich Hersel, Mathias Krusch, Biodegradable polyethylene glycol based water-insoluble hydrogels ,(2010)
Thomas Wegge, Harald Rau, Ulrich Hersel, Dirk Vetter, N, n-bis- (2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs ,(2006)
Bernd Sauerbrei, Herbert Waldmann, Uwe Grether, Enzyme cleavable linker bound to solid phase for organic compound synthesis ,(1997)
Harald Rau, Silvia Kaden-Vagt, Interferon alpha carrier prodrugs ,(2010)